A carregar...
Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
Radiolabeled magnetic nanoparticles are promising candidates as dual-modality-contrast-agents (DMCA) for diagnostic applications. The immunocompatibility of a new DMCA is a prerequisite for subsequent in vivo applications. Here, a new DMCA, namely Fe(3)O(4) nanoparticles radiolabeled with (68)Ga, is...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8105398/ https://ncbi.nlm.nih.gov/pubmed/33963211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-89117-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|